Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Boehringer Ingelheim Hepatitis C Drugs Cured 82% in Trial
Boehringer Ingelheim Hepatitis C Drugs Cured 82% in Trial
Boehringer Ingelheim Hepatitis C Drugs Cured 82% in Trial
Submitted by
admin
on April 19, 2012 - 10:36am
Source:
Bloomberg
News Tags:
Boehringer Ingelheim
hepatitis C
BI 201335
protease inhibitors
nucleoside polymerase inhibitor
BI 207127
Headline:
Boehringer Ingelheim Hepatitis C Drugs Cured 82% in Trial
Do Not Allow Advertisers to Use My Personal information
